Atlas FDA

HYBRITECH(R) TANDEM (R) PSA ASSAY IMMUNOMETRIC

FDA premarket approval P850048/S009 · decided 1994-08-25

Approval details

PMA number
P850048
Supplement
S009
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
HYBRITECH(R) TANDEM (R) PSA ASSAY IMMUNOMETRIC
Generic name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Applicant
Beckman Coulter, Inc.
Date received
1992-06-29
Decision date
1994-08-25
Days to decision
787 days
Decision code
APPR
Product code
LTJ
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20